Nuria Pastor

From 01/10/2024 to 15/03/2025

Open Ideas

Vitalera

Temple University

Nuria Pastor Hernández, M.Sc. is a Digital Health Executive and CEO of Vitalera, scaling operations to 30+ healthcare organizations globally. With 10+ years in international business development, she specializes in healthcare innovation, strategic planning, and market expansion. She secured €3.3M in public funding and led Vitalera’s U.S. expansion in 2024. Nuria holds advanced degrees in health research and psychology and completed Stanford’s Scale-Up program. Previously, she contributed to mental health research and digital health validation. Passionate about AI-driven healthcare solutions, she drives impactful change in patient monitoring and early intervention. Fluent in English, Catalan, French, and Spanish. Living in Philadelphia for 6 months with potential stations.

VITALERA is an AI-powered remote care solution that is transforming healthcare delivery by enhancing both in-patient and out-patient services for improved patient outcomes.

Collaborating with top institutions like Harvard Medical School and Beth Israel Deaconess Medical Center, as well as hospitals, insurance companies, and life science organizations, Vitalera is leading AI-driven remote care to predict readmissions and health events.

Its advanced AI technology enables seamless health monitoring without Bluetooth or device connectivity, supporting conditions such as cardiology, respiratory issues, oncology, behavioral health, and diabetes. Patients receive personalized, real-time insights through AI-generated reports.

The platform is HIPAA and GDPR-compliant, evidence-based, and CE-marked for medical software, ensuring top-tier privacy, security, and regulatory compliance.

addresses the growing challenge of ensuring continuous, timely, and efficient healthcare, particularly for an aging population.

The healthcare industry faces an increasing gap between supply and demand, with limited resources to provide real-time medical assistance. VITALERA leverages AI-powered remote patient monitoring and wearable technology to bridge this gap, offering scalable and efficient solutions.

Through the NGI Enrichers program, VITALERA aims to expand into the U.S. market, capitalizing on partnerships with scientific and academic institutions to validate its solution and accelerate adoption. With demonstrated market traction in Europe and a B2B model licensing to healthcare organizations, the project is well-positioned for scalability and international growth.

The soft-landing strategy focuses on:

• Market Validation: Engaging with S. healthcare stakeholders to refine product-market fit.
• Regulatory Compliance: Advancing in EEUU certification for specific healthcare needs.
• Strategic Partnerships: Establishing collaborations with research institutions and hospitals.
• Business Development: Exploring and creating solid funding opportunities and securing local pilot implementations.

With its agnostic hardware positioning and AI-driven approach, VITALERA is poised to make a significant impact in the U.S. healthcare landscape.

Starting from the expected outcomes in our application, the NGI Enrichers Fellowship has accelerated VITALERA’s entry into the U.S. market, fostering key partnerships and refining our strategy for scalability. The core outcomes include:

• Market Entry & Validation: Successfully testing VITALERA’s AI-driven remote patient monitoring in the U.S. healthcare ecosystem.
• Regulatory Progress: Advancing with the current adaptations to comply with U.S. healthcare standards.
• Scientific & Clinical Validation: Strengthening evidence-based support for AI-powered remote monitoring solutions, with current collaborations with Harvard Medical School.
• Business & Investment Readiness: Expanding engagement with potential partners, and industrial partners to secure funding and accelerate commercialization.
• Strategic Partnerships: Establishing collaborations with leading U.S, with other research institutions, hospitals, and healthcare organizations.
• Technical Integration & Product Development: Refining technical integration with U.S. healthcare systems through pilots and demo projects.

The NGI Enrichers Fellowship has driven significant advancements in multiple areas:

Development/Advancement of Innovative Technologies

• Strengthened AI-powered patient monitoring with insights from U.S. stakeholders.
• Improved scalability and integration with wearable and telemedicine systems.

Testing Technologies in the U.S. Market

• Launched pilot projects with U.S. healthcare organizations to validate product-market fit.
• Secured early adoption opportunities with B2B healthcare providers.

Scientific Validation & Standards Advancement

• Conducted clinical studies and validation in collaboration with U.S. institutions.
• Aligned with international standards for data security and AI-driven healthcare applications.

Strengthening Research & Innovation Collaboration

• Established joint projects with U.S. academic and research centers.
• Reinforced engagement with EU-U.S. digital health initiatives.

Building Business & Investment Networks

• Accelerated connections with U.S. investors, VCs, and industry leaders.
• Explored funding opportunities, including public grants and private investments.

Fundraising & Future Collaboration

• Developed proposals for funding from U.S. and European public organizations, some introductions, and great healthcare networks.
• Strengthened links within the NGI community for future research and business collaborations.

Academic & Professional Growth

• Supported scientific publications with Harvard and conferences such as the American Diabetes Association or HTLH showcasing our technology.
• Enhanced professional networks.

Through this fellowship, VITALERA has significantly accelerated its global growth, reinforcing its mission to bridge healthcare accessibility gaps through AI-powered digital health solutions.